Evidence map›Paper›PMID 36670122›Full record

ArticleNature communications2023

Integrative genetic analysis illuminates ALS heritability and identifies risk genes.

Salim Megat, Natalia Mora, Jason Sanogo, Olga Roman, Alberto Catanese, Najwa Ouali Alami, Axel Freischmidt, Xhuljana Mingaj, Hortense De Calbiac, François Muratet and 29 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Exploring dysregulated miRNAs in ALS: implications for disease pathogenesis and early diagnosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. SLP2/PHB Aggregates in ALS Mouse Models and Patients: Implications BeyondInternational journal of molecular sciences · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. microRNA in ALS: finally ready for prime time?Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors at 11 institutions in 6 countries.

Salim MegatUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, UMR-S1118, Centre de Recherches en Biomédecine, Strasbourg, France. salim.megat@inserm.fr.ORCID http://orcid.org/0000-0003-2186-6770
Natalia MoraDepartment of Molecular Neurobiology, Donders Institute for Brain, Cognition and Behaviour and Faculty of Science, Radboud University, Nijmegen, Netherlands.ORCID http://orcid.org/0000-0002-2183-7753
Jason SanogoUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, UMR-S1118, Centre de Recherches en Biomédecine, Strasbourg, France.
Olga RomanUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, UMR-S1118, Centre de Recherches en Biomédecine, Strasbourg, France.
Alberto CataneseInstitute of Anatomy and Cell Biology, Ulm University, Ulm, Germany.ORCID http://orcid.org/0000-0002-8266-4913
Najwa Ouali AlamiClinical Neuroanatomy, Department of Neurology, Ulm University, Ulm, Germany.
Axel FreischmidtGerman Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.
Xhuljana MingajLaboratory of Translational Research for Neurological Disorders, Imagine Institute, Université de Paris, INSERM UMR 1163, 75015, Paris, France.
Hortense De CalbiacLaboratory of Translational Research for Neurological Disorders, Imagine Institute, Université de Paris, INSERM UMR 1163, 75015, Paris, France.
François MuratetSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.
Sylvie Dirrig-GroschUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, UMR-S1118, Centre de Recherches en Biomédecine, Strasbourg, France.
Stéphane DieterleUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, UMR-S1118, Centre de Recherches en Biomédecine, Strasbourg, France.
Nick Van BakelDepartment of Molecular Neurobiology, Donders Institute for Brain, Cognition and Behaviour and Faculty of Science, Radboud University, Nijmegen, Netherlands.
Kathrin MüllerGerman Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.
Kirsten SieverdingGerman Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.
Jochen WeishauptDivision for Neurodegenerative Diseases, Neurology Department, University Medicine Mannheim, Heidelberg University, Mannheim, Germany.
Peter Munch AndersenDepartment of Clinical Science, Neurosciences, Umea University, Umea, Sweden.ORCID http://orcid.org/0000-0003-0094-5429
Markus WeberNeuromuscular Disease Unit/ALS Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID http://orcid.org/0000-0002-5538-9274
Christoph NeuwirthNeuromuscular Disease Unit/ALS Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID http://orcid.org/0000-0002-1874-8872
Markus MargelischInstitute for Pathology, Kanstonsspital St. Gallen, St. Gallen, Switzerland.
Andreas SommacalInstitute for Pathology, Kanstonsspital St. Gallen, St. Gallen, Switzerland.
Kristel R Van EijkDepartment of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
Jan H VeldinkDepartment of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0001-5572-9657
Project Mine Als Sequencing Consortium
Géraldine LautretteService de Neurologie, Centre de Référence SLA et autres maladies du neurone moteur, CHU Dupuytren 1, Limoges, France.
Philippe CouratierService de Neurologie, Centre de Référence SLA et autres maladies du neurone moteur, CHU Dupuytren 1, Limoges, France.
Agnès CamuzatSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.
Isabelle Le BerSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.
Maurizio GrassanoALS Center "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Adriano ChioALS Center "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Tobias BoeckersInstitute of Anatomy and Cell Biology, Ulm University, Ulm, Germany.ORCID http://orcid.org/0000-0002-1486-8535
Albert C LudolphGerman Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.
Francesco RoselliGerman Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.
Deniz Yilmazer-HankeClinical Neuroanatomy, Department of Neurology, Ulm University, Ulm, Germany.
Stéphanie Millecamps *Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.ORCID http://orcid.org/0000-0002-0745-6735
Edor Kabashi *Laboratory of Translational Research for Neurological Disorders, Imagine Institute, Université de Paris, INSERM UMR 1163, 75015, Paris, France.
Erik Storkebaum *Department of Molecular Neurobiology, Donders Institute for Brain, Cognition and Behaviour and Faculty of Science, Radboud University, Nijmegen, Netherlands.ORCID http://orcid.org/0000-0002-9519-5642
Chantal Sellier *Université de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, UMR-S1118, Centre de Recherches en Biomédecine, Strasbourg, France.
Luc Dupuis *Université de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, UMR-S1118, Centre de Recherches en Biomédecine, Strasbourg, France. ldupuis@unistra.fr.ORCID http://orcid.org/0000-0002-0902-5824
Inserm · FRUniversität Ulm · DECentre National de la Recherche Scientifique · FRKantonsspital St. Gallen · CHRadboud University Nijmegen · NLHôpital Dupuytren · FRUniversity of Turin · ITUtrecht University · NLGerman Center for Neurodegenerative Diseases · DEUmeå University · SEUniversity of Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) has substantial heritability, in part shared with fronto-temporal dementia (FTD). We show that ALS heritability is enriched in splicing variants and in binding sites of 6 RNA-binding proteins including TDP-43 and FUS. A transcriptome wide association study (TWAS) identified 6 loci associated with ALS, including in NUP50 encoding for the nucleopore basket protein NUP50. Independently, rare variants in NUP50 were associated with ALS risk (P = 3.71.10

Indexed as

Amyotrophic Lateral SclerosisFrontotemporal DementiaAnimalsDisease Models, AnimalHumansMutationNeuronsRNA-Binding Protein FUSZebrafishRNA-Binding Protein FUS

Identifiers

PMID36670122
PMCPMC9860017
OpenAlexW4317581917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.